Neurocrine Biosciences (NBIX) Tax Rate Growth (3y) (2022 - 2026)
Neurocrine Biosciences (NBIX) Tax Rate Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.39 Bn | 30.45 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.59 Bn | 23.53 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.27 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 18.00 Bn | 16.69 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -603.00 |
| Dec 31, 2025 | 1,129.00 |
| Sep 30, 2025 | -183.00 |
| Jun 30, 2025 | 513.00 |
| Mar 31, 2025 | 1,121.00 |
| Dec 31, 2024 | -1,051.00 |
| Sep 30, 2024 | 556.00 |
| Jun 30, 2024 | 764.00 |
| Mar 31, 2024 | -778.00 |
| Dec 31, 2023 | 75,977.00 |
| Sep 30, 2023 | 2,899.00 |
| Jun 30, 2023 | 1,714.00 |
| Mar 31, 2023 | 2,199.00 |
| Dec 31, 2022 | 1,260.00 |
| Sep 30, 2022 | 2,215.00 |
| Jun 30, 2022 | 2,593.00 |
| Mar 31, 2022 | 3,456.00 |